Assessment of Early Pregnancy MAB Completion

Running, not enrolling

Conditions studied: Pregnancy, Abortion Early

In brief

This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.

Key facts

Study ID

NCT06893484

Run by

University of Washington

People needed

400

Starts

2025-03-13

Expected to finish

2026-06-01

Last updated by the study team

2026-05-08

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant person with early pregnancy ≤42 days
• Eligible and consented to a medication abortion
• Have access to receiving text messages and the internet
• Able to read and understand English

You may not qualify if…

• Privacy or safety concerns about filling out the surveys

Where it is running

• Carafem — Atlanta, Georgia, United States
• Carafem — Chevy Chase, Maryland, United States
• Cedar River Clinics — Renton, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.